Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dictyostelium | 16 | 2017 | 114 | 2.110 |
Why?
|
| Computational Biology | 12 | 2016 | 820 | 1.980 |
Why?
|
| Gene Expression Profiling | 16 | 2017 | 1762 | 1.640 |
Why?
|
| User-Computer Interface | 7 | 2017 | 155 | 1.580 |
Why?
|
| Software | 10 | 2014 | 687 | 1.290 |
Why?
|
| Artificial Intelligence | 6 | 2013 | 244 | 0.950 |
Why?
|
| Database Management Systems | 4 | 2013 | 31 | 0.730 |
Why?
|
| Algorithms | 11 | 2016 | 1634 | 0.680 |
Why?
|
| Databases, Genetic | 4 | 2014 | 478 | 0.660 |
Why?
|
| Computer Graphics | 4 | 2014 | 38 | 0.610 |
Why?
|
| Models, Genetic | 6 | 2014 | 761 | 0.550 |
Why?
|
| Internet | 5 | 2017 | 377 | 0.520 |
Why?
|
| Data Compression | 1 | 2016 | 12 | 0.520 |
Why?
|
| Semantics | 1 | 2016 | 25 | 0.520 |
Why?
|
| Sequence Analysis, RNA | 4 | 2017 | 373 | 0.490 |
Why?
|
| Drug Interactions | 1 | 2016 | 257 | 0.470 |
Why?
|
| Disease | 1 | 2016 | 129 | 0.470 |
Why?
|
| Databases, Factual | 3 | 2013 | 1186 | 0.470 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 1034 | 0.460 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2653 | 0.430 |
Why?
|
| Models, Statistical | 2 | 2014 | 472 | 0.420 |
Why?
|
| Multigene Family | 3 | 2017 | 302 | 0.410 |
Why?
|
| Information Storage and Retrieval | 3 | 2007 | 58 | 0.400 |
Why?
|
| Genomics | 6 | 2010 | 1524 | 0.390 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 233 | 0.370 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 7 | 0.350 |
Why?
|
| Hip Joint | 1 | 2010 | 38 | 0.340 |
Why?
|
| Cell Differentiation | 4 | 2013 | 1916 | 0.340 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 165 | 0.340 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2010 | 95 | 0.300 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 1694 | 0.290 |
Why?
|
| Cluster Analysis | 3 | 2017 | 406 | 0.280 |
Why?
|
| Protozoan Proteins | 4 | 2013 | 111 | 0.280 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2014 | 427 | 0.280 |
Why?
|
| Data Mining | 3 | 2013 | 53 | 0.280 |
Why?
|
| Databases, Protein | 1 | 2007 | 56 | 0.280 |
Why?
|
| Models, Biological | 2 | 2016 | 1469 | 0.280 |
Why?
|
| Biomedical Engineering | 1 | 2007 | 28 | 0.280 |
Why?
|
| Clinical Medicine | 1 | 2006 | 21 | 0.270 |
Why?
|
| Chromosome Mapping | 2 | 2011 | 1085 | 0.260 |
Why?
|
| Statistics as Topic | 1 | 2006 | 257 | 0.250 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 196 | 0.240 |
Why?
|
| Proteome | 1 | 2007 | 246 | 0.240 |
Why?
|
| Programming Languages | 1 | 2004 | 19 | 0.230 |
Why?
|
| Computer Simulation | 4 | 2014 | 654 | 0.230 |
Why?
|
| Gene Regulatory Networks | 4 | 2017 | 363 | 0.230 |
Why?
|
| Genes | 1 | 2005 | 447 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 2528 | 0.220 |
Why?
|
| Precision Medicine | 2 | 2018 | 322 | 0.220 |
Why?
|
| Expert Systems | 1 | 2003 | 15 | 0.210 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 682 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2832 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 1011 | 0.190 |
Why?
|
| Gene Expression | 3 | 2011 | 1562 | 0.190 |
Why?
|
| Oogenesis | 2 | 2012 | 56 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 887 | 0.180 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 809 | 0.180 |
Why?
|
| Signal Transduction | 3 | 2011 | 4600 | 0.160 |
Why?
|
| Transcriptome | 2 | 2017 | 980 | 0.160 |
Why?
|
| Oocytes | 2 | 2012 | 299 | 0.160 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1536 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 1763 | 0.150 |
Why?
|
| Biomedical Research | 3 | 2008 | 519 | 0.150 |
Why?
|
| Pyrophosphatases | 1 | 2017 | 21 | 0.140 |
Why?
|
| DNA, Complementary | 3 | 2013 | 462 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 239 | 0.130 |
Why?
|
| Bayes Theorem | 2 | 2016 | 285 | 0.130 |
Why?
|
| Pattern Recognition, Automated | 2 | 2008 | 49 | 0.130 |
Why?
|
| Gene Ontology | 1 | 2016 | 46 | 0.130 |
Why?
|
| Databases, Pharmaceutical | 1 | 2016 | 3 | 0.130 |
Why?
|
| Classification | 1 | 2016 | 18 | 0.130 |
Why?
|
| Neoplasms | 2 | 2008 | 2806 | 0.130 |
Why?
|
| Systems Integration | 1 | 2016 | 27 | 0.130 |
Why?
|
| Mutation | 5 | 2013 | 5909 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2016 | 114 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2016 | 88 | 0.120 |
Why?
|
| Spores, Protozoan | 2 | 2013 | 18 | 0.120 |
Why?
|
| Probability | 1 | 2016 | 322 | 0.120 |
Why?
|
| Genome, Protozoan | 2 | 2013 | 25 | 0.120 |
Why?
|
| Epistasis, Genetic | 2 | 2005 | 94 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2011 | 158 | 0.120 |
Why?
|
| DNA Primers | 2 | 2013 | 658 | 0.120 |
Why?
|
| DNA, Fungal | 1 | 2014 | 77 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 572 | 0.110 |
Why?
|
| Animals | 12 | 2012 | 34392 | 0.110 |
Why?
|
| Wine | 1 | 2013 | 15 | 0.110 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 222 | 0.110 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 199 | 0.100 |
Why?
|
| Base Sequence | 3 | 2013 | 3110 | 0.100 |
Why?
|
| RNA, Protozoan | 1 | 2013 | 10 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 47 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 68 | 0.100 |
Why?
|
| Machine Learning | 1 | 2016 | 251 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3897 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 190 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 148 | 0.100 |
Why?
|
| Gene Library | 1 | 2013 | 218 | 0.100 |
Why?
|
| Biological Evolution | 2 | 2010 | 227 | 0.100 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 42 | 0.090 |
Why?
|
| Humans | 14 | 2018 | 125757 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 107 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Nucleotides | 1 | 2010 | 92 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2010 | 144 | 0.080 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 245 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2010 | 291 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 1592 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1707 | 0.080 |
Why?
|
| Systems Biology | 1 | 2008 | 58 | 0.080 |
Why?
|
| Genome | 1 | 2011 | 480 | 0.070 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2008 | 19 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2010 | 355 | 0.070 |
Why?
|
| RNA | 1 | 2011 | 576 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2014 | 1506 | 0.070 |
Why?
|
| Social Behavior | 1 | 2009 | 208 | 0.070 |
Why?
|
| Crush Syndrome | 1 | 2007 | 4 | 0.070 |
Why?
|
| Rescue Work | 1 | 2007 | 11 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 578 | 0.070 |
Why?
|
| Stem Cells | 1 | 2011 | 712 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2006 | 36 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 642 | 0.060 |
Why?
|
| Triage | 1 | 2007 | 139 | 0.060 |
Why?
|
| Biometry | 1 | 2007 | 136 | 0.060 |
Why?
|
| Disasters | 1 | 2007 | 103 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 818 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 947 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3728 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 858 | 0.060 |
Why?
|
| Knowledge | 1 | 2003 | 47 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 1444 | 0.050 |
Why?
|
| Phenotype | 4 | 2014 | 4274 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2003 | 240 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 278 | 0.050 |
Why?
|
| Larva | 1 | 2003 | 248 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 695 | 0.050 |
Why?
|
| Research | 1 | 2003 | 262 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1536 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 226 | 0.050 |
Why?
|
| Genes, Protozoan | 2 | 2013 | 25 | 0.050 |
Why?
|
| Mice | 3 | 2012 | 17758 | 0.040 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 204 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6609 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2006 | 1051 | 0.040 |
Why?
|
| DNA | 1 | 2003 | 1616 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 44 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 3470 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 222 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2017 | 295 | 0.030 |
Why?
|
| Protein Binding | 2 | 2011 | 1758 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 259 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 509 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 688 | 0.030 |
Why?
|
| United States | 2 | 2008 | 10941 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 247 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2015 | 212 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 146 | 0.030 |
Why?
|
| Middle Aged | 2 | 2010 | 27003 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2762 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 210 | 0.020 |
Why?
|
| Aged | 1 | 2010 | 19899 | 0.020 |
Why?
|
| Blastomeres | 1 | 2012 | 7 | 0.020 |
Why?
|
| Female | 4 | 2012 | 67035 | 0.020 |
Why?
|
| Sarcoglycans | 1 | 2011 | 7 | 0.020 |
Why?
|
| Muscle Development | 1 | 2011 | 71 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 253 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 238 | 0.020 |
Why?
|
| Uridine | 1 | 2010 | 34 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3416 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 513 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2010 | 19 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2010 | 67 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1980 | 0.020 |
Why?
|
| Adult | 1 | 2010 | 29760 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2011 | 228 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2010 | 62 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 551 | 0.020 |
Why?
|
| Regeneration | 1 | 2011 | 214 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 702 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 807 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1299 | 0.020 |
Why?
|
| Education | 1 | 2008 | 109 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2569 | 0.020 |
Why?
|
| Europe | 1 | 2008 | 357 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6173 | 0.020 |
Why?
|
| Male | 2 | 2010 | 61813 | 0.020 |
Why?
|
| Pulse | 1 | 2007 | 29 | 0.020 |
Why?
|
| Urine | 1 | 2007 | 91 | 0.020 |
Why?
|
| Tachycardia | 1 | 2007 | 70 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 135 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 768 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 250 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 31 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 189 | 0.020 |
Why?
|
| Retroelements | 1 | 2006 | 41 | 0.020 |
Why?
|
| Hyperkalemia | 1 | 2007 | 67 | 0.020 |
Why?
|
| Chromosomes | 1 | 2006 | 207 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2010 | 496 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 1341 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1021 | 0.010 |
Why?
|
| CpG Islands | 1 | 2006 | 330 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 149 | 0.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 140 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6355 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1817 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 2183 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 2617 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 3098 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2007 | 4853 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 4700 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2007 | 16434 | 0.000 |
Why?
|